Codiak Biosciences
$0.06
37
-$0.07-55.98% Tuesday 22:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
2.1M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
3MayExpected
Expected EPS
-0.485
Actual EPS
N/A
Financials
-162.01%Profit Margin
Unprofitable22.94MRevenue
-37.16MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CDAK. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Commercial Services
Miscellaneous Commercial Services
Health Technology
Pharmaceuticals: Major
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Douglas Williams
Employees
102
Country
US
ISIN
US1920101060
WKN
000A2PJN7
Listings
0 Comments
Share your thoughts
FAQ
What is Codiak Biosciences stock price today?▼
The current price of CDAK is $0.06 USD — it has decreased by -55.98% in the past 24 hours. Watch Codiak Biosciences stock price performance more closely on the chart.
What is Codiak Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Codiak Biosciences stocks are traded under the ticker CDAK.
What is Codiak Biosciences market cap?▼
Today Codiak Biosciences has the market capitalization of 2.1M
What is Codiak Biosciences revenue for the last year?▼
Codiak Biosciences revenue for the last year amounts to 22.94M USD.
What is Codiak Biosciences net income for the last year?▼
CDAK net income for the last year is -37.16M USD.
How many employees does Codiak Biosciences have?▼
As of April 02, 2026, the company has 102 employees.
In which sector is Codiak Biosciences located?▼
Codiak Biosciences operates in the Manufacturing sector.
When did Codiak Biosciences complete a stock split?▼
Codiak Biosciences has not had any recent stock splits.
Where is Codiak Biosciences headquartered?▼
Codiak Biosciences is headquartered in Cambridge, US.